Skip to content
TrialScanner

NCT06603844

First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

Phase 1/Phase 2CompletedCRBPLead

Registry record

Lead sponsor
Corbus Pharmaceuticals Inc.
Conditions
Solid Tumor
Primary completion
Jan 30, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06603844 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

3 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06603844: First-in-human Study of... | TrialScanner